Sandbox:DAMI: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
== Overview == | |||
== Historical Perspective == | |||
== Classification == | |||
== Pathophysiology == | |||
== Causes == | |||
== Differentiating Gynecomastia from Other Diseases == | |||
== Epidemiology and Demographics == | |||
__NOTOC__ | __NOTOC__ | ||
| Line 37: | Line 50: | ||
=== Causes === | === Causes === | ||
== | == Screening == | ||
==Natural History, Complication and Prognosis== | |||
== Diagnosis == | |||
== Treatment == | |||
== | == Case study == | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 15:36, 18 May 2017
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Gynecomastia from Other Diseases
Epidemiology and Demographics
Gynecomastia risk factors
Risk factors
- The most potent risk factor in the development of gynecomastia is idiopathic often multifactorial.
Common Risk Factors
- Idiopathic
- Drugs (12765)
- Cirrhosis
- Starvation and Refeeding
- Male hypogonadism
- Testicular neoplasms
- Hyperthyroidism
- Chronic Kidney disease
- Tumors
Less Common Risk Factors
- Feminizing adrenal tumors
- Ectopic hCG
- Disorders of sex development
- Familial prepubertal gynecomastia
Causes
Screening
Natural History, Complication and Prognosis
Diagnosis
Treatment
Case study
References
- ↑ Braunstein GD (1993). "Gynecomastia". N Engl J Med. 328 (7): 490–5. doi:10.1056/NEJM199302183280708. PMID 8421478.